Prostate Cancer - Results from #560

Single-dose high-dose-rate brachytherapy versus two and three fractions for locally advanced prostate cancer. July 18, 2024

Predicting Treatment Effects from Surrogate Endpoints in Historical Trials in First-Line Metastatic Castration-Resistant Prostate Cancer. July 18, 2024

Bayer Announces Positive Topline Results for NUBEQA® (Darolutamide) from Phase III Trial in Men with Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) July 17, 2024

The Current Landscape of Stereotactic Body Radiation Therapy for Metastatic Castration-Resistant Prostate Cancer - Beyond the Absract July 17, 2024

Helical Tomotherapy versus Three-Dimensional Conformal Radiotherapy in High Risk Prostate Cancer: A Phase III Randomized Controlled Trial. July 17, 2024

Stereotactic Body Radiotherapy for Oligoprogression in Castration-Resistant Prostate Cancer: Early Toxicity Analysis of the TRAP Trial. July 17, 2024

Health-related quality of life in ethnically diverse Black prostate cancer survivors: a convergent parallel mixed-methods approach. July 17, 2024

Diagnostic performance of ADC and ADCratio in MRI-based prostate cancer assessment: A systematic review and meta-analysis. July 17, 2024

Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancer. July 17, 2024

Financial Distress in Genitourinary Cancer: Insights From CDC National Health Interview Survey. July 17, 2024

Cancer misinformation on social media July 16, 2024

Mediating Effects of Self-Efficacy and Illness Perceptions on Mental Health in Men with Localized Prostate Cancer: A Secondary Analysis of the Prostate Cancer Patient Empowerment Program (PC-PEP) Randomized Controlled Trial. July 16, 2024

Risk of cardiovascular events following intermittent and continuous androgen deprivation therapy in patients with nonmetastatic prostate cancer. July 16, 2024

Anatomic Locations and Metastatic Risk in Prostate Cancer in African Men: Insights From an African Cohort. July 16, 2024

Multiparametric Prostate MRI Accuracy of Prostate Imaging Reporting and Data System (v2.1) Scores 4 and 5: The Influence of Image Quality According to the Prostate Imaging Quality Score. July 16, 2024

Effect of Radical Prostatectomy on Survival for Men with High-risk Nonmetastatic Prostate Cancer Features Selected According to STAMPEDE Criteria: An EMPaCT Study. July 16, 2024

Plain language summary of the results from the TALAPRO-2 study: Talazoparib plus enzalutamide versus placebo plus enzalutamide for patients with advanced prostate cancer. July 16, 2024

Restaging With Prostate-Specific Membrane Antigen Imaging in Metastatic Castration-Resistant Prostate Cancer: When Seeing More Is Detrimental to Care. July 16, 2024

Circulating Tumor DNA Assessment for Treatment Monitoring Adds Value to PSA in Metastatic Castration Resistant Prostate Cancer. July 15, 2024

Clinical Trial Protocol for VIOLET: A Single-Center, Phase I/II Trial Evaluation of Radioligand Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer with [161Tb]Tb-PSMA-I&T. July 15, 2024

Page 29 of 1435